Neil Kumar - Aug 16, 2022 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: CEO and President, Director
Signature: /s/ Brian C. Stephenson, Attorney-in-Fact
Stock symbol: BBIO
Transactions as of: Aug 16, 2022
Transactions value $: -$306,883
Form type: 4
Date filed: 8/18/2022, 06:39 PM
Previous filing: May 18, 2022
Next filing: Nov 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBIO	Common Stock	Options Exercise		+68.7K	+1.44%		4.84M	Aug 16, 2022	Direct	F1
transaction	BBIO	Common Stock	Tax liability	-$307K	-27.7K	-0.57%	$11.08	4.81M	Aug 16, 2022	Direct	F2
holding	BBIO	Common Stock						1.61M	Aug 16, 2022	See Footnote	F3
holding	BBIO	Common Stock						1.2M	Aug 16, 2022	See Footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-5.13K	-12.5%	$0.00	35.9K	Aug 16, 2022	Common Stock	5.13K		Direct	F1, F5
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-2.39K	-9.09%	$0.00	23.9K	Aug 16, 2022	Common Stock	2.39K		Direct	F1, F6
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-61.2K	-14.29%	$0.00	367K	Aug 16, 2022	Common Stock	61.2K		Direct	F1, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 68,705 shares of Common Stock underlying the Reporting Person's RSUs.
F3	The shares are held by Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F4	The shares are held by Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.
F5	The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F6	The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F7	The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.